Patients will face delays in getting diagnostic scans due to severe shortage of imaging agentsSeptember 08, 2008Letter: Medical isotope supplies and nuclear medicine services A global shortage of medical isotopes* used in over 80% of routine diagnostic nuclear imaging procedures such as heart imaging, bone scans and some cancer detection procedures, will cause delays and cancellations to diagnostic examinations across the UK and Europe in the next few weeks, predict experts on bmj.com today. UK hospitals are receiving less than 50% of expected supplies and rations are expected to drop still further in the coming weeks, write Alan Perkins and colleagues from the British Nuclear Medicine Society.
According to the European Association of Nuclear Medicine European hospitals are already limited to only 20��% of normal nuclear medical activities. The authors warn that if NHS managers in the UK aim to meet the six-week target for diagnostic waiting times by altering bookings on the basis of waiting times rather than clinical priority, some patients may receive sub-optimal treatment. Currently Europe's three isotope production reactors are all shut down because of maintenance issues and European producers only have enough radioisotopes to last until September 8. In addition, other reactors in Canada and South Africa have also been temporarily closed, leaving just the Australian reactor which, according to the authors, does not have enough potential to significantly increase supply to the world market. The closure of the Canadian reactor for two months in 2007 for safety reasons affected over 50 000 patient examinations in the US. The authors point out that this is not just a short term emergency. Most of the commercial reactors are around 40 years old and new production capacity is urgently needed to meet the increasing demands of isotopes for research, diagnosis and treatment. They warn that urgent global investment in new reactor facilities is essential or these problems will continue and it will be the patients that suffer. BMJ-British Medical Journal | |||||||||||||||||||||
|
Related Nuclear Medicine Current Events and Nuclear Medicine News Articles Fibromyalgia can no longer be called the 'invisible' syndrome Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed. MU scientists go green with gold, distribute environmentally friendly nanoparticles Gold nanoparticles are everywhere. They are used in cancer treatments, automobile sensors, cell phones, blood sugar monitors and hydrogen gas production. Carbon molecule with a charge could be tomorrow's semiconductor Virginia Tech chemistry Professor Harry Dorn has developed a new area of fullerene chemistry that may be the backbone for development of molecular semiconductors and quantum computing applications. The future of non-invasive cardiac imaging Imaging has gained attention in many areas of medicine but its relevance and importance in clinical cardiology cannot be underestimated. PET scans lead to treatment changes in majority of colorectal cancer patients In the largest multi-institutional study to date examining the impact of positron emission tomography (PET) in changing disease management of individuals with suspected recurrent colorectal cancer, researchers found that treatment plans were changed for more than half of patients. Nature or Nurture-Are You Who Your Brain Chemistry Says You Are? Researchers using positron emission tomography (PET) have validated a long-held theory that individual personality traits-particularly reward dependency-are connected to brain chemistry, a finding that has implications for better understanding and treating substance abuse and other addictive behaviors. MDCT just as accurate as MRI in assessing myocardial infarction in emergency setting Multidetector CT (MDCT) is just as accurate as MRI in assessing myocardial infarct size--an important predictor of clinical outcome-- in an emergency setting according to a recent study conducted by researchers in collaboration between the VA Medical Center in San Francisco, CA and the University Claude Bernard in Lyon, France. Chest Pain Center Accreditation Linked with Better Outcomes in Heart Attack Patients Hospitals accredited by the Society of Chest Pain Centers (SCPC) have been shown to perform better in the heart attack core measures established by Centers for Medicare and Medicaid Services (CMS) as compared to non-accredited hospitals, according to a national study led by an Emory University researcher. Fair and adequate reimbursement is vital to developing life-saving medical treatments Reimbursement of molecular imaging and therapies-leading to the early detection and diagnosis of many life-threatening diseases-remains an urgent and critical need as consumers face ever-increasing healthcare costs. PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer Combined positron emission tomography (PET) and computed tomography (CT) scanning of patients in the early stages of ovarian cancer can enable physicians to determine whether the cancer has spread to nearby lymph nodes without having to perform surgery. More Nuclear Medicine Current Events and Nuclear Medicine News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||